Anupong Tangpeerachaikul
Covalent Associates (United States)(US)
Publications by Year
Research Areas
Lung Cancer Treatments and Mutations, Chronic Myeloid Leukemia Treatments, Click Chemistry and Applications, Lung Cancer Research Studies, Cytokine Signaling Pathways and Interactions
Most-Cited Works
- → Mediator kinase inhibition further activates super-enhancer-associated genes in AML(2015)400 cited
- → Fast, Cell‐Compatible Click Chemistry with Copper‐Chelating Azides for Biomolecular Labeling(2012)335 cited
- → Diels–Alder Cycloaddition for Fluorophore Targeting to Specific Proteins inside Living Cells(2011)253 cited
- → Identification of Mediator Kinase Substrates in Human Cells using Cortistatin A and Quantitative Phosphoproteomics(2016)163 cited
- → NVL-520 Is a Selective, TRK-Sparing, and Brain-Penetrant Inhibitor of ROS1 Fusions and Secondary Resistance Mutations(2022)47 cited
- → NVL-655 Is a Selective and Brain-Penetrant Inhibitor of Diverse ALK-Mutant Oncoproteins, Including Lorlatinib-Resistant Compound Mutations(2024)43 cited
- → Abstract 1468: NUV-655 (NVL-655) is a selective, brain-penetrant ALK inhibitor with antitumor activity against the lorlatinib-resistant G1202R/L1196M compound mutation(2021)27 cited
- → Abstract 1465: NUV-520 (NVL-520) is a brain-penetrant and highly selective ROS1 inhibitor with antitumor activity against the G2032R solvent front mutation(2021)4 cited
- → Zidesamtinib Selective Targeting of Diverse ROS1 Drug-Resistant Mutations(2025)3 cited